![](/img/cover-not-exists.png)
426 Dual interleukin-17A and interleukin-17F neutralisation with bimekizumab provides evidence for interleukin-17F contribution to immune-mediated inflammatory skin response
Maroof, A., Smallie, T., Archer, S., Simpson, C., Griffiths, M., Baeten, D., Shaw, S.Volume:
137
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2017.07.622
Date:
October, 2017
File:
PDF, 428 KB
english, 2017